Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Aprea Therapeutics, Inc. (APRE) had Return on Tangible Equity of -27.24% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.00M |
|
$-2.97M |
|
-- |
|
$0.00M |
|
$3.12M |
|
$-3.12M |
|
$0.14M |
|
$-2.97M |
|
$-2.97M |
|
$-2.97M |
|
$-2.97M |
|
$-2.97M |
|
$-2.97M |
|
$-3.12M |
|
$-3.11M |
|
6.37M |
|
6.37M |
|
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$13.94M |
|
$0.07M |
|
$0.38M |
|
$14.32M |
|
$2.68M |
|
-- |
|
$0.73M |
|
$3.41M |
|
$10.91M |
|
$10.91M |
|
$10.91M |
|
5.98M |
|
| Cash Flow Statement Financials | |
$-9.93M |
|
-- |
|
$0.80M |
|
$22.89M |
|
$13.76M |
|
$-9.13M |
|
$0.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.20 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.93M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-27.24% |
|
|
Return on Tangible Equity |
-27.24% |
-20.76% |
|
-27.24% |
|
$1.83 |
|
$-1.56 |
|
$-1.56 |
|